Niki BioSolutions NIKI
NASDAQ NIKI
$4.90 +0.16 (+3.38%)
At close: Sep 30, 2026 · 4:00 PM EDT

Niki BioSolutions (NIKI) Debt Ratio (2017 - 2024)

Updated

Niki BioSolutions' (NIKI) Debt Ratio came in at 0.21 for FY2024, up 35.3% from 0.15 in FY2023.

Analysis

Niki BioSolutions (NIKI) Debt Ratio (2017 - 2024) Analysis & Trends

Since FY2017, Niki BioSolutions has reported Debt Ratio for 8 years.

  • Annual Debt Ratio has run from a low of 0.00 in FY2021 to a high of 0.31 in FY2022 over five years.
  • Business Quant data shows NIKI's Debt Ratio at 0.15 in FY2023 (-51.3%), 0.31 in FY2022, 0.00 in FY2021 (-98.9%) and 0.05 in FY2020 (-82.8%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 0.24
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 0.52
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 0.42
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 0.31
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 0.00
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 0.60
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 0.53
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Niki BioSolutions 2.67 Mn 2.67 Mn - -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2024 1.06
Dec 31, 2023 0.15
Jun 30, 2023 0.01
Dec 31, 2022 0.31
Jun 30, 2022 0.12
Dec 31, 2021 0.00
Jun 30, 2021 0.03
Dec 31, 2020 0.05
Jun 30, 2020 0.10
Dec 31, 2019 0.26
Jun 30, 2019 0.00
Dec 31, 2018 0.30
Dec 31, 2017 0.02
API Access

Niki BioSolutions Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=NIKI&period=max&api_key=YOUR_API_KEY